Ronchi Giulia, Ackva Christina, Fregnan Federica, Zen Federica, Muratori Luisa, Crosio Alessandro, Metzen Jennifer, Haastert-Talini Kirsten
Department of Clinical and Biological Sciences & Neuroscience Institute Cavalieri Ottolenghi (NICO), University of Torino, 10043 Orbassano, Italy.
KeriMedical, Route des Acacias, 45a, 1227 Genf, Switzerland.
Int J Mol Sci. 2025 Jan 30;26(3):1214. doi: 10.3390/ijms26031214.
Before clinical approval of chitosan nerve conduits (CNCs) less than 10 years ago, substantial material degradation was not reported from pre-clinical research. The current study investigated the biodegradation of two different CNC variants in the median nerve model. In adult rats, 10 mm long CNCs were secured covering end-to-end repair sites. After 2, 6, 12, and 18 months, the implantation sites were inspected, and samples harvested. Histology was performed in order to analyze local immune response or foreign body tissue reaction around the devices or within nerve samples. Further, the number of myelinated nerve fibers and the condition of the chitosan material was evaluated. Data confirmed that different CNC variants did not induce tissue reaction or negatively impact the condition of the regenerated nerve. At late time points, some specific variants were demonstrated to have resulted in encapsulated material debris in the vicinity of the original implantation side. The reported degradation behavior resembles recent clinical reports and indicates that implantation sites for CNCs need to be chosen carefully. Nerve regeneration itself is undisturbed, but narrow implantation sites should be avoided for eliminating the risk of foreign body sensation with immunologically inert material degradation.
在不到10年前壳聚糖神经导管(CNCs)获得临床批准之前,临床前研究并未报告有明显的材料降解情况。本研究在正中神经模型中调查了两种不同CNC变体的生物降解情况。在成年大鼠中,将10毫米长的CNC固定在端端修复部位。在2、6、12和18个月后,检查植入部位并采集样本。进行组织学检查以分析装置周围或神经样本内的局部免疫反应或异物组织反应。此外,评估有髓神经纤维的数量和壳聚糖材料的状况。数据证实,不同的CNC变体不会诱导组织反应或对再生神经的状况产生负面影响。在后期时间点,一些特定变体被证明在原始植入侧附近导致了包封的材料碎片。所报告的降解行为与近期临床报告相似,表明CNCs的植入部位需要谨慎选择。神经再生本身未受干扰,但应避免狭窄的植入部位,以消除免疫惰性材料降解导致异物感的风险。